The advanced therapy sector will weather the current financing storm, but thousands of skilled workers are still needed for it to achieve its potential, says JIB’s Parviz Shamlou. In 2019, the Jefferson Institute for Bioprocessing (JIB) opened its doors in Philadelphia, Pennsylvania to support the sector, providing training across all functions of bioprocessing including for cell and gene therapies (CGTs), which the region is renowned for. The Institute is currently undergoing a facility expansion program that will add pilot-scale production…
Friday, April 7, 2023 Daily Archives
Seagen: ADC pipeline drove Washington $350m+ plant buildout
‘The reason we are building a new facility in Everett, Washington is threefold, but primarily it is about our pipeline,’ says firm. Antibody-drug conjugate (ADC) developer Seagen (previously Seattle Genetics), which is set to be acquired by Pfizer for $43 billion, announced plans in April 2022 to spend between $350 and $400 million to construct a greenfield biomanufacturing site in Everett, Washington. The decision to build the 270,000 square-foot facility “is threefold, but primarily it is about our pipeline and…